{"id":"W2784258094","doi":"10.1002/cncr.31234","title":"Long‐term outcome of dasatinib first‐line treatment in gastrointestinal stromal tumor: A multicenter, 2‐stage phase 2 trial (Swiss Group for Clinical Cancer Research 56/07)","year":2018,"lang":"en","type":"article","venue":"Cancer","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung; Bristol-Myers Squibb Canada; Bristol-Myers Squibb","keywords":"Medicine; Dasatinib; GiST; Clinical endpoint; Imatinib mesylate; Internal medicine; Clinical trial; Imatinib; Positron emission tomography; Progressive disease; Tyrosine-kinase inhibitor; Phases of clinical research; Cancer; Surgery; Gastroenterology; Chemotherapy; Nuclear medicine; Stromal cell","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001206013,0.000383764,0.0009848694,0.0003127283,0.00014828,0.00003180221,0.0002554665,0.00006026276,0.001010358],"category_scores_gemma":[0.001140689,0.0002907039,0.0004511869,0.0003369159,0.00074143,0.00009607914,0.0001195409,0.0005040645,0.0000342701],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001118938,"about_ca_system_score_gemma":0.0007282178,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002855978,"about_ca_topic_score_gemma":0.007119912,"domain_scores_codex":[0.9957755,0.0002501573,0.00125349,0.0008045518,0.0007336162,0.001182661],"domain_scores_gemma":[0.9970253,0.0007626367,0.0002951431,0.0006014558,0.0006653266,0.0006501356],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1549439,0.007877713,0.8263772,0.0004046836,0.0001784682,0.0008401305,0.0001292149,0.00000353059,0.001088853,0.00002485448,0.000430954,0.007700495],"study_design_scores_gemma":[0.4442309,0.1184755,0.4266455,0.002882394,0.0003241645,0.000162758,0.0001739789,0.001569315,0.003019203,0.00003009345,0.002114371,0.0003719133],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9923511,0.0004443893,0.0003093522,0.001282841,0.0002961671,0.004531842,0.000640748,0.0000406102,0.0001029162],"genre_scores_gemma":[0.9910669,0.0001490946,0.003149366,0.00008184111,0.00202668,0.002189361,0.0001080811,0.0000661815,0.001162552],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3997317,"threshold_uncertainty_score":0.9999545,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3396339336548623,"score_gpt":0.5669099352753292,"score_spread":0.2272760016204668,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}